Urinary Catheter Exchange on Admission of Septic Elderly With Permanent Catheter Before Initiation of Antibiotics

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2007 by Shaare Zedek Medical Center.
Recruitment status was  Not yet recruiting
Information provided by:
Shaare Zedek Medical Center
ClinicalTrials.gov Identifier:
First received: July 17, 2007
Last updated: NA
Last verified: July 2007
History: No changes posted

In the era of emerging antibiotics resistant microbiology, we look for better outcome in the treatment of infections in the elderly.

We look for guidelines to manage an elderly who has a permanent urinary catheter, admitting to E.R. with Fever/Sepsis.

We assume that exchanging the permanent urinary catheter prior to the Urine Culture sample as well as for initiating antibiotic treatment will improve the outcome of the patients.It could help the day-to-day fight for the proper antibiotics treatment to avoid resistance.

Heart Rate
Blood Pressure
C-Reactive Protein
Erythrocyte Sedimentation Rate

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Longitudinal

Resource links provided by NLM:

Further study details as provided by Shaare Zedek Medical Center:

Study Start Date: October 2007
Estimated Study Completion Date: October 2007

Ages Eligible for Study:   65 Years to 95 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • >65 years
  • Permanent Urinary Catheter
  • FEVER or Septic State

Exclusion Criteria:

  • Supra-Pubic Aspiration Catheters
  • Septic Shock
  • I.V. Antibiotics Initiated before admission
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00503282

Contact: Ron Ben - Itzhak, M.D. 972-544500187 ronbenitzhak@yahoo.com

Sponsors and Collaborators
Shaare Zedek Medical Center
Principal Investigator: Ron Ben - Itzhak HEBREW UNIVERSITY, JERUSALEM
  More Information

ClinicalTrials.gov Identifier: NCT00503282     History of Changes
Other Study ID Numbers: uc.ctil 
Study First Received: July 17, 2007
Last Updated: July 17, 2007
Health Authority: Israel: Ethics Commission

ClinicalTrials.gov processed this record on May 24, 2016